Huamao Wang

2 ta ish

Regend Therapeutics (China)

1. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

   Changsong Qi, Jifang Gong, Jian Li +23

   MaqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.102908

2. Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

   Hua Jiang, Zhimin Shi, Peng Wang +9

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.431542